Deflating the neuroenhancement bubble

AJOB Neuroscience

Volumn 2, Issue 4, 2011, Pages 38-43

  Lucke, Jayne C ^a   Bell, Stephanie ^a   Partridge, Brad ^a   Hall, Wayne D ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

cognitive enhancement; drug use; evidence; neuroenhancement; neuropharmaceuticals; smart drugs

Indexed keywords

EID: 82355162967     PISSN: 21507740     EISSN: 21507759     Source Type: Journal    
DOI: 10.1080/21507740.2011.611122     Document Type: Article

References (47)

1. Academy of Medical Sciences. 2008. Brain science, addiction and drugs. United Kingdom 2008 Available at: http://www.acmedsci.ac.uk/index.php?pid = 99&puid = 126 (accessed July 1, 2010)
2. Advokat, C. 2009. What exactly are the benefits of stimulants for ADHD?. Journal of Attention Disorders, 12(6): 495-498.
3. Arria, A. M., Caldeira, K. M.O'Grady, K. E. 2008. Nonmedical use of prescription stimulants among college students: Associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy, 28(2): 156-169.
4. Babcock, Q. and Byrne, T. 2000. Student perceptions of methylphenidate abuse at a public liberal arts college. Journal of American College Health, 49(3): 143-145.
5. Bogle, K. E. and Smith, B. H. 2009. Illicit methylphenidate use: A review of prevalence, availability, pharmacology, and consequences. Current Drug Abuse Reviews, 2(2): 157-176.
6. British Medical Association. 2007. Boosting your brainpower: Ethical aspects of cognitive enhancements (discussion paper) London Available at: http://www.bma.org.uk/ethics/health_technology/CognitiveEnhancement2007.jsp (accessed July 1, 2010)
7. Bush, S. S. 2006. Neurocognitive enhancement: Ethical considerations for an emerging subspecialty. Applied Neuropsychology, 13(2): 125-136.
8. de Jongh, R., Bolt, I., Schermer, M. and Olivier, B. 2008. Botox for the brain: Enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience Biobehavioural Reviews, 32(4): 760-776.
9. DeSantis, A., Noar, S. M. and Webb, E. M. 2009. Nonmedical ADHD stimulant use in fraternities. Journal of Studies on Alcohol and Drugs, 70(6): 952-954.
10. Diller, L. H. 1996. The run on ritalin. Attention deficit disorder and stimulant treatment in the 1990s. The Hastings Center Report, 26(2): 12-18.
11. Elliott, C. 2004. Pharma goes to the laundry: Public relations and the business of medical education. The Hastings Center Report, 34(5): 18-23.
12. Farah, M. J. 2005. Neuroethics: The practical and the philosophical. Trends in Cognitive Science, 9(1): 34-40.
13. Farah, M. J., Illes, J.Cook-Deegan, R. 2004. Neurocognitive enhancement: What can we do and what should we do?. Nature Reviews Neuroscience, 5(5): 421-425.
14. Greely, H., Sahakian, B.Harris, J. 2008. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456(7223): 702-705.
15. Healy, D. 2006. Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression, New York: New York University Press.
16. Jones, R., Morris, K. and Nutt, D. 2007. "Cognition enhancers". In In Drugs and the future: Brain Science, addiction and society, Edited by: Nutt, D., Robbins, T. W., Stimson, G. V., Ince, M. and Jackson, A. 242-283. Oxford: Elsevier.
17. Keane, H. 2008. Pleasure and discipline in the uses of ritalin. International Journal of Drug Policy, 19(5): 401-409.
18. Koelch, M., Schnoor, K. and Fegert, J. M. 2008. Ethical issues in psychopharmacology of children and adolescents. Current Opinion in Psychiatry, 21(6): 598-605.
19. Kumar, R. 2008. Approved and investigational uses of modafinil: An evidence-based review. Drugs, 68(13): 1803-1839.
20. Larriviere, D., Williams, M. A., Rizzo, M. and Bonnie, R. J. 2009. Responding to requests from adult patients for neuroenhancements. Guidance of the Ethics, Law and Humanities Committee. Neurology, 73(17): 1406-1412.
21. Maher, B. 2008. Poll results: look who's doping. Nature, 452(7188): 674-675.
22. McCabe, S. E. 2008a. Misperceptions of non-medical prescription drug use: A web survey of college students. Addictive Behaviors, 33(5): 713-724.
23. McCabe, S. E. 2008b. Screening for drug abuse among medical and nonmedical users of prescription drugs in a probability sample of college students. Archives of Pediatrics & Adolescent Medicine, 162(3): 225-231.
24. McCabe, S. E., Knight, J. R., Teter, C. J. and Wechsler, H. 2005a. Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction, 100(1): 96-106.
25. McCabe, S. E., Teter, C. J., Boyd, C. J. and Guthrie, S. K. 2004. Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. Journal of Adolescent Health, 35(6): 501-504.
26. McCabe, S. E., Teter, C. J., Boyd, C. J., Knight, J. R. and Wechsler, H. 2005b. Nonmedical use of prescription opioids among US college students: prevalence and correlates from a national survey. Addictive Behaviors, 30(4): 789-805.
27. Mehlman, M. J. 2004. Cognition-enhancing drugs. Milbank Quarterly, 82(3): 483-506.
28. Minzenberg, M. J. and Carter, C. S. 2008. Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology, 33(7): 1477-1502.
29. Novak, S. P., Kroutil, L. A., Williams, R. L. and Van Brunt, D. L. 2007. The nonmedical use of prescription ADHD medications: Results from a national internet panel. Substance Abuse Treatment, Prevention, & Policy, 2: 32
30. Outram, S. M. 2010. The use of methylphenidate among students: The future of enhancement?. Journal of Medical Ethics, 36(4): 198-202.
31. Peterkin, A. L., Crone, C. C., Sheridan, M. J. and Wise, T. N. 2010. Cognitive performance enhancement: misuse or self-treatment?. Journal of Attention Disorders., doi:doi: 10.1177/1087054710365980
32. Quednow, B. B. 2010. Ethics of neuroenhancement: A phantom debate. BioSocieties, 5(1): 153-156.
33. Racine, E. and Forlini, C. 2009. Expectations regarding cognitive enhancement create substantial challenges. Journal of Medical Ethics, 35(8): 469-470.
34. Rasmussen, N. 2008. On speed: The many lives of amphetamine, New York: New York University Press.
35. Sahakian, B. and Morein-Zamir, S. 2007. Professor's little helper. Nature, 450(7173): 1157-1159.
36. Sargant, W. and Blackburn, J. M. 1936. The effect of benzedrine on intelligence scores. Lancet, 228(5911): 1385-1387.
37. Schermer, M., Bolt, I., de Jongh, R. and Olivier, B. 2009. The future of psychopharmacological enhancements: Expectations and policies. Neuroethics, 2(2): 75-87.
38. Singh, I. and Kelleher, K. J. 2010. Neuroenhancement in young people: Proposal for research, policy, and clinical management. AJOB Neuroscience, 1(1): 3-16.
39. Smith, L. 1939. Collapse with death following the use of amphetmine sulfate. Journal of American Medical Association, 113(11): 1023-1024.
40. Substance Abuse and Mental Health Services Administration. 2010. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings Rockville, MD Available at: http://www.oas.samhsa.gov/NSDUH/2k9NSDUH/2k9Results.htm (accessed November 18, 2010)
41. Svetlov, S. I., Kobeissy, F. H. and Gold, M. S. 2007. Performance enhancing, non-prescription use of Ritalin: A comparison with amphetamines and cocaine. Journal of Addictive Diseases, 26(4): 1-6.
42. Teter, C. J., McCabe, S. E., LaGrange, K., Cranford, J. A. and Boyd, C. J. 2006. Illicit use of specific prescription stimulants among college students: Prevalence, motives, and routes of administration. Pharmacotherapy, 26(10): 1501-1510.
43. Teter, C. J., Falone, A. E., Cranford, J. A., Boyd, C. J. and McCabe, S. E. 2010. Nonmedical use of prescription stimulants and depressed mood among college students: Frequency and routes of administration. Journal of Substance Abuse Treatment, 38(3): 292-298.
44. Tomasi, D., Volkow, N. D.Wang, G. J. 2010. Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls. Neuroimage, doi:doi: 10.1016/j.neuroimage.2010.1010.1060
45. Turner, D. C., Robbins, T. W.Clark, L. 2003. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology, 165(3): 260-269.
46. Upadhyaya, H. P., Kroutil, L. A.Deas, D. 2010. Stimulant formulation and motivation for nonmedical use of prescription attention-deficit/hyperactivity disorder medications in a college-aged population. American Journal on Addictions, 19(6): 569-577.
47. Warren, O. J., Leff, D. R., Athanasiou, T., Kennard, C. and Darzi, A. 2009. The neurocognitive enhancement of surgeons: An ethical perspective. Journal of Surgical Research, 152(1): 167-172.